Cargando…

Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia

BACKGROUND: Isoimmunization is a process of immunizing an antigen-negative pregnant individual with a paternally derived fetal antigen. Although the Rh systems contain many antigen subtypes (D, C, c, E, e), the RhD antigen is highly immunogenic. This research aimed to investigate the perinatal Outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Kureba, Abdulhakim Abdurahman, Gudu, Wondimu, Mersha, Anteneh, Jemal, Elias, Abdosh, Abdulfetah Abdulkadir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106785/
https://www.ncbi.nlm.nih.gov/pubmed/37077284
http://dx.doi.org/10.2147/IJWH.S402373
_version_ 1785026481875845120
author Kureba, Abdulhakim Abdurahman
Gudu, Wondimu
Mersha, Anteneh
Jemal, Elias
Abdosh, Abdulfetah Abdulkadir
author_facet Kureba, Abdulhakim Abdurahman
Gudu, Wondimu
Mersha, Anteneh
Jemal, Elias
Abdosh, Abdulfetah Abdulkadir
author_sort Kureba, Abdulhakim Abdurahman
collection PubMed
description BACKGROUND: Isoimmunization is a process of immunizing an antigen-negative pregnant individual with a paternally derived fetal antigen. Although the Rh systems contain many antigen subtypes (D, C, c, E, e), the RhD antigen is highly immunogenic. This research aimed to investigate the perinatal Outcome of pregnant women with RhD sensitization at St. Paul’s Hospital Millennium Medical College (SPHMMC), Ethiopia. METHODOLOGY: A facility-based retrospective cross-sectional study was conducted on 98 pregnant women with RhD alloimmunization at SPHMMC from September 11, 2016, to September 10, 2021. SPSS 26 was used for data analysis. Descriptive statistics were utilized to assess the perinatal outcome of pregnant women with RhD alloimmunization. Fisher’s exact test was used to determine which association, and a P value <0.05 was considered statistically significant. RESULTS: From the 98 pregnancies (06 - hydropic, 92 - non-hydropic) at high risk for fetal anemia, 45.9% of cases had MCA-PSV above 1.5MoM. Among these, 21.42% of all fetuses received an intrauterine transfusion. Forty-three IUTs were performed in 21 fetuses. The median number of transfusions per fetus was two. About 52.4% of the transfused fetuses had severe anemia, and 28.6% had moderate anemia. Prediction of MCA PSV ≥1.5MOM in diagnosing moderate-severe anemia in pregnant women with RhD sensitization 81%. General neonatal survival of alloimmunizations was 93.8%, 90.5% with IUT, 50% with hydrops fetalis, and 96.7% without hydrops. CONCLUSION: This research provides evidence that MCA PSV ≥1.5MoM is modest predictor of moderate-severe anemia in untransfused fetuses. This study was a step toward the development of more extensive and multicenter studies on the Perinatal Outcome of pregnant women with RhD sensitization in Ethiopia. Extra studies are needed to evaluate strategies for estimates of fetal anemia after blood transfusion as a result of the absence of information on the IUT database.
format Online
Article
Text
id pubmed-10106785
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-101067852023-04-18 Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia Kureba, Abdulhakim Abdurahman Gudu, Wondimu Mersha, Anteneh Jemal, Elias Abdosh, Abdulfetah Abdulkadir Int J Womens Health Original Research BACKGROUND: Isoimmunization is a process of immunizing an antigen-negative pregnant individual with a paternally derived fetal antigen. Although the Rh systems contain many antigen subtypes (D, C, c, E, e), the RhD antigen is highly immunogenic. This research aimed to investigate the perinatal Outcome of pregnant women with RhD sensitization at St. Paul’s Hospital Millennium Medical College (SPHMMC), Ethiopia. METHODOLOGY: A facility-based retrospective cross-sectional study was conducted on 98 pregnant women with RhD alloimmunization at SPHMMC from September 11, 2016, to September 10, 2021. SPSS 26 was used for data analysis. Descriptive statistics were utilized to assess the perinatal outcome of pregnant women with RhD alloimmunization. Fisher’s exact test was used to determine which association, and a P value <0.05 was considered statistically significant. RESULTS: From the 98 pregnancies (06 - hydropic, 92 - non-hydropic) at high risk for fetal anemia, 45.9% of cases had MCA-PSV above 1.5MoM. Among these, 21.42% of all fetuses received an intrauterine transfusion. Forty-three IUTs were performed in 21 fetuses. The median number of transfusions per fetus was two. About 52.4% of the transfused fetuses had severe anemia, and 28.6% had moderate anemia. Prediction of MCA PSV ≥1.5MOM in diagnosing moderate-severe anemia in pregnant women with RhD sensitization 81%. General neonatal survival of alloimmunizations was 93.8%, 90.5% with IUT, 50% with hydrops fetalis, and 96.7% without hydrops. CONCLUSION: This research provides evidence that MCA PSV ≥1.5MoM is modest predictor of moderate-severe anemia in untransfused fetuses. This study was a step toward the development of more extensive and multicenter studies on the Perinatal Outcome of pregnant women with RhD sensitization in Ethiopia. Extra studies are needed to evaluate strategies for estimates of fetal anemia after blood transfusion as a result of the absence of information on the IUT database. Dove 2023-04-12 /pmc/articles/PMC10106785/ /pubmed/37077284 http://dx.doi.org/10.2147/IJWH.S402373 Text en © 2023 Kureba et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Kureba, Abdulhakim Abdurahman
Gudu, Wondimu
Mersha, Anteneh
Jemal, Elias
Abdosh, Abdulfetah Abdulkadir
Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia
title Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia
title_full Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia
title_fullStr Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia
title_full_unstemmed Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia
title_short Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia
title_sort perinatal outcome of pregnant women with rhd sensitization: a five-year cross-sectional study at a tertiary care hospital in ethiopia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106785/
https://www.ncbi.nlm.nih.gov/pubmed/37077284
http://dx.doi.org/10.2147/IJWH.S402373
work_keys_str_mv AT kurebaabdulhakimabdurahman perinataloutcomeofpregnantwomenwithrhdsensitizationafiveyearcrosssectionalstudyatatertiarycarehospitalinethiopia
AT guduwondimu perinataloutcomeofpregnantwomenwithrhdsensitizationafiveyearcrosssectionalstudyatatertiarycarehospitalinethiopia
AT mershaanteneh perinataloutcomeofpregnantwomenwithrhdsensitizationafiveyearcrosssectionalstudyatatertiarycarehospitalinethiopia
AT jemalelias perinataloutcomeofpregnantwomenwithrhdsensitizationafiveyearcrosssectionalstudyatatertiarycarehospitalinethiopia
AT abdoshabdulfetahabdulkadir perinataloutcomeofpregnantwomenwithrhdsensitizationafiveyearcrosssectionalstudyatatertiarycarehospitalinethiopia